Excerpt from Washington Post article 'It pays to read the warnings when you open up a prescription' by Idelle Davidson. To read the full article, click here
"Plaintiffs claim that the company failed to adequately warn physicians of the risk of tendon injuries associated with Levaquin, a drug with about $1.3 billion in sales in the United States in 2010. Most cases have been settled or dismissed.
Separately, about 60 product liability cases are pending in federal court against Johnson & Johnson and against Bayer for Cipro and Avelox, alleging their products caused irreversible peripheral neuropathy or nerve damage and were sold without adequate warnings of risk. Helping coordinate the effort is the patient advocacy group Quinolone Vigilance Foundation.
Rachel Brummert, executive director of the foundation, says the pharmaceutical industry should do more to warn physicians of the risk of injury. “Doctors are largely in the dark,” she says. “The few patients who are warned are not told that these adverse reactions can be permanent.”
This article has been picked up by Tulsa World and the Hartford Courant.
Author Idelle Davidson Davidson writes about health and is co-author of “Your Brain After Chemo: A Practical Guide to Lifting the Fog and Getting Back Your Focus.”